Original Research
Published on 14 Jul 2022
APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants
in Modeling of Viral Replication and Pathogenesis
- 2,977 views
- 3 citations





















